Skip to main content
Molecular Cancer logoLink to Molecular Cancer
. 2020 Sep 4;19:137. doi: 10.1186/s12943-020-01257-8

Correction to: YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma

Jiajie Hou 1,2,3,4,✉,#, He Zhang 1,5,#, Jun Liu 6,#, Zhenjun Zhao 1, Jianye Wang 1, Zhike Lu 6, Bian Hu 7, Jiankui Zhou 7, Zhicong Zhao 1, Mingxuan Feng 1, Haiyan Zhang 4,8, Bin Shen 9, Xingxu Huang 7, Beicheng Sun 2, Mark J Smyth 8, Chuan He 6,10,, Qiang Xia 1,
PMCID: PMC7650264  PMID: 32887624

Correction to: Mol Cancer 18, 163 (2019)

https://doi.org/10.1186/s12943-019-1082-3

Following the publication of the original article [1], the author list lacked a co-author’s name: Mark J. Smyth, and his affiliation is QIMR Berghofer Medical Research Institute. The correct author list should be “Jiajie Hou; He Zhang; Jun Liu; Zhenjun Zhao; Jianye Wang; Zhike Lu; Bian Hu; Jiankui Zhou; Zhicong Zhao; Mingxuan Feng; Haiyan Zhang; Bin Shen; Xingxu Huang; Beicheng Sun; Mark J. Smyth; Chuan He; Qiang Xia”. The error has been corrected in the HTML and PDF version of this article.

Footnotes

Jiajie Hou, He Zhang and Jun Liu contributed equally to this work.

Contributor Information

Jiajie Hou, Email: houjj@sysucc.org.cn.

Chuan He, Email: chuanhe@uchicago.edu.

Qiang Xia, Email: xiaqiang@shsmu.edu.cn.

Reference

  • 1.Hou J, Zhang H, Liu J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Mol Cancer. 2019;18:163. doi: 10.1186/s12943-019-1082-3. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES